Medicinal chitin fiber for preventing mammary gland hyperplasia, and its preparation and use
A technology for chitin fiber and mammary gland hyperplasia, which is applied in the field of medicinal fibers, can solve problems such as strong odor, and achieve the effects of simple production process, easy implementation and convenient medication.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] A preparation method of medicinal chitin fiber for preventing and treating mammary gland hyperplasia:
[0024] The first step is to prepare spinning dope. The chitin-containing spinning dope is firstly prepared according to the existing technology, and each component is calculated by weight percentage, wherein the dry solid content of chitin is 99%. Then the medicine for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator are added in the spinning stock solution and stirred evenly. 0.5%;
[0025] The second step is to make medicinal chitin or chitosan fibers from the spinning stock solution containing anti-mammary gland hyperplasia drugs and drug transdermal absorption accelerators, and use wet spinning technology to make medicinal chitin or chitosan fibers. The sugar fiber not only contains chitin or chitosan, but also contains drugs for preventing and treating mammary gland hyperplasia and drug transdermal absorption acc...
Embodiment 2
[0033] In this embodiment, the dry solid content A of chitin or chitosan in the spinning dope is 80%, the dry solid content of the drug for preventing and treating mammary gland hyperplasia is 15%, and the dry solid content of the drug transdermal absorption accelerator is 5%.
[0034] The method is as follows: making medicinal chitin or chitosan fiber from the spinning stock solution containing the drug for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator, and spinning the fiber by a dry spinning process.
Embodiment 3
[0036] In this embodiment, the dry solid content of chitin or chitosan in the spinning dope is 70%, the dry solid content of the drug for preventing and treating mammary gland hyperplasia is 20%, and the dry solid content of the drug transdermal absorption accelerator is 10%.
[0037] The method is as follows: making medicinal chitin or chitosan fiber from the spinning stock solution containing the drug for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator, and adopting a dry spray wet spinning process.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com